A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

NCT07251166 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GenSci140 for Injection

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.